JP2008519833A5 - - Google Patents

Download PDF

Info

Publication number
JP2008519833A5
JP2008519833A5 JP2007541137A JP2007541137A JP2008519833A5 JP 2008519833 A5 JP2008519833 A5 JP 2008519833A5 JP 2007541137 A JP2007541137 A JP 2007541137A JP 2007541137 A JP2007541137 A JP 2007541137A JP 2008519833 A5 JP2008519833 A5 JP 2008519833A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
heterocyclyl
cycloalkenyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2007541137A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008519833A (ja
Filing date
Publication date
Priority claimed from SE0402762A external-priority patent/SE0402762D0/sv
Application filed filed Critical
Publication of JP2008519833A publication Critical patent/JP2008519833A/ja
Publication of JP2008519833A5 publication Critical patent/JP2008519833A5/ja
Abandoned legal-status Critical Current

Links

JP2007541137A 2004-11-11 2005-11-07 インダゾールスルホンアミド誘導体 Abandoned JP2008519833A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0402762A SE0402762D0 (sv) 2004-11-11 2004-11-11 Indazole sulphonamide derivatives
PCT/SE2005/001669 WO2006052190A1 (en) 2004-11-11 2005-11-07 Indazole sulphonamide derivatives

Publications (2)

Publication Number Publication Date
JP2008519833A JP2008519833A (ja) 2008-06-12
JP2008519833A5 true JP2008519833A5 (https=) 2008-12-25

Family

ID=33488225

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007541137A Abandoned JP2008519833A (ja) 2004-11-11 2005-11-07 インダゾールスルホンアミド誘導体

Country Status (6)

Country Link
US (1) US20080004288A1 (https=)
EP (1) EP1814863A1 (https=)
JP (1) JP2008519833A (https=)
CN (1) CN101098858A (https=)
SE (1) SE0402762D0 (https=)
WO (1) WO2006052190A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008024284A2 (en) * 2006-08-21 2008-02-28 Merck & Co., Inc. Sulfonylated piperazines as cannabinoid-1 receptor modulators
CA2704684A1 (en) * 2007-11-07 2009-05-14 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
CA2758071C (en) 2009-04-06 2018-01-09 Agios Pharmaceuticals, Inc. Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use
TWI598337B (zh) 2009-06-29 2017-09-11 阿吉歐斯製藥公司 治療化合物及組成物
ES2618630T3 (es) * 2009-06-29 2017-06-21 Agios Pharmaceuticals, Inc. Composiciones terapéuticas y métodos de uso relacionados
WO2012083246A1 (en) 2010-12-17 2012-06-21 Agios Pharmaceuticals, Inc. Novel n- (4- (azetidine - 1 - carbonyl) phenyl) - (hetero - ) arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators
ES2569712T3 (es) 2010-12-21 2016-05-12 Agios Pharmaceuticals, Inc. Activadores de PKM2 bicíclicos
TWI549947B (zh) 2010-12-29 2016-09-21 阿吉歐斯製藥公司 治療化合物及組成物
EP2487159A1 (en) 2011-02-11 2012-08-15 MSD Oss B.V. RorgammaT inhibitors
SMT202400081T1 (it) 2011-05-03 2024-03-13 Agios Pharmaceuticals Inc Attivatori della piruvato chinasi per uso in terapia
US9181231B2 (en) 2011-05-03 2015-11-10 Agios Pharmaceuticals, Inc Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
WO2014026327A1 (en) 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. 4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof
WO2014026330A1 (en) * 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
US9388179B2 (en) * 2012-10-26 2016-07-12 Merck Sharp & Dohme Corp. N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels
WO2014139144A1 (en) 2013-03-15 2014-09-18 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
US9573946B2 (en) * 2014-02-20 2017-02-21 Novita Pharmaceuticals, Inc. Compounds and methods for inhibiting fascin
FR3030518B1 (fr) 2014-12-19 2018-03-23 Galderma Research & Development Derives sulfonamides en tant qu'agonistes inverses du recepteur gamma orphelin associe aux retinoides ror gamma (t)
FR3030516B1 (fr) 2014-12-19 2019-12-27 Galderma Research & Development Derives sulfonamides bicycles en tant qu'agonistes inverses du recepteur gamma orphelin associe aux retinoides ror gamma (t)
CA2975997A1 (en) 2015-02-11 2016-08-18 Merck Sharp & Dohme Corp. Substituted pyrazole compounds as rorgammat inhibitors and uses thereof
CA2989111C (en) 2015-06-11 2023-10-03 Agios Pharmaceuticals, Inc. Methods of using pyruvate kinase activators
JP2018535958A (ja) 2015-10-27 2018-12-06 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. RORγT阻害薬としての置換インダゾール化合物及びその使用
EP3368535B1 (en) 2015-10-27 2020-12-02 Merck Sharp & Dohme Corp. Heteroaryl substituted benzoic acids as rorgammat inhibitors and uses thereof
US10344000B2 (en) 2015-10-27 2019-07-09 Merck Sharp & Dohme Corp. Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof
US20240066027A1 (en) * 2020-12-03 2024-02-29 Domain Therapeutics Novel par-2 inhibitors
CN119095828A (zh) * 2022-03-31 2024-12-06 江苏恒瑞医药股份有限公司 吲唑类化合物、其制备方法及其在医药上的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795227A1 (de) * 1968-08-24 1971-11-04 Basf Ag Neue basische Azofarbstoffe der Indazolreihe
DE2653005A1 (de) * 1975-12-03 1977-06-08 Sandoz Ag Neue organische verbindungen, ihre verwendung und herstellung
US4981613A (en) * 1986-11-04 1991-01-01 Fuji Photo Film Co., Ltd. Laser light source
US5378714A (en) * 1991-11-27 1995-01-03 Novo Nordisk A/S Antipsychotic piperidine derivatives
US5612360A (en) * 1992-06-03 1997-03-18 Eli Lilly And Company Angiotensin II antagonists
US5760246A (en) * 1996-12-17 1998-06-02 Biller; Scott A. Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
EP1169038B9 (en) * 1999-04-15 2013-07-10 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
SE0101387D0 (sv) * 2001-04-20 2001-04-20 Astrazeneca Ab Novel compounds
FR2836914B1 (fr) * 2002-03-11 2008-03-14 Aventis Pharma Sa Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
US7378441B2 (en) * 2004-05-07 2008-05-27 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors

Similar Documents

Publication Publication Date Title
JP2008519833A5 (https=)
CN101679287B (zh) 烟碱型乙酰胆碱受体调节剂
ES2442926T3 (es) Derivados de ciclopropilamida `978
US20080004288A1 (en) Indazole Sulphonamide Derivatives
US20070225292A1 (en) Therapeutic Compounds: Pyridine as Scaffold
CN1882581A (zh) N-[杂芳基(哌啶-2-基)甲基]苯甲酰胺衍生物及其制备方法和它们的治疗应用
JP2005526723A5 (https=)
US20090111865A1 (en) Benzimidazole Derivatives, Compositions Containing Them, Preparation Thereof and Uses Thereof
JP2005519908A5 (https=)
HUP0301114A2 (hu) Pirrolo[2,3-d]pirimidin vegyületek, mint immunoszuppresszív hatóanyagok, és ezeket tartalmazó gyógyszerkészítmények
EP2231159A1 (en) Method of treating arthritis
AU2018309372B2 (en) Methods of treating behavior alterations
JP2004507527A5 (https=)
KR20060017863A (ko) 벤즈이미다졸 유도체, 그를 포함하는 조성물, 및 그의 제조방법 및 그의 용도
ES2286474T3 (es) Derivados de 4-(finilpiperazinilmetil) benzamida y su uso para el tratamiento de dolor o transtornos gastrointestinales.
CN100471844C (zh) 4-(苯基-哌嗪基-甲基)苯甲酰胺衍生物及其在治疗疼痛或胃肠疾病中的用途
JP2015526475A5 (https=)
JP2003529597A5 (https=)
JP2019501126A5 (https=)
JP2007520536A5 (https=)
ES2285179T3 (es) Derivados de fenil-piperidin-4-ilidene-metil-benzamida para el tratamiento de dolor o trastornos gastrointestinales.
US20070265325A1 (en) Nitro Indazole Derivatives
JP4137956B2 (ja) 複素環化合物
ZA200505189B (en) Diarylmethylidene piperidine derivatives, preperations thereof and uses thereof
US7244850B2 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof